Related Experiment Video

Updated: Aug 2, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Role for glucagon as a mineralocorticoid antagonist during the fetal-perinatal period

A F DiNicola

    Medical Hypotheses
    |January 1, 1983
    PubMed

    Insights

    Newborns experience significant fluid and sodium loss after birth. This may be due to reduced kidney response to aldosterone, potentially influenced by glucagon, affecting both term and premature infants.

    Area of Science:

    • Neonatal physiology
    • Endocrinology
    • Renal function

    Background:

    • Total body water (TBW) and sodium progressively decrease during the fetal-perinatal period.
    • Term infants typically lose 5-10% of their birth weight in water during the first 3-4 postnatal days.
    • Premature infants experience even greater TBW and sodium losses in the first postnatal week.

    Purpose of the Study:

    • To investigate the potential mechanisms behind significant postnatal fluid and sodium loss in infants.
    • To explore the role of renal hyporesponsiveness to aldosterone in neonatal water and sodium balance.

    Main Methods:

    • The abstract does not specify methods, but implies analysis of physiological changes in neonatal fluid and electrolyte balance.

    Main Results:

    • Postnatal decreases in TBW and sodium may be partly explained by impaired renal distal tubular response to aldosterone.
    • This hyporesponsiveness might be mediated by glucagon.
    • The findings are relevant to both term and premature infants.

    Conclusions:

    • Glucagon-mediated renal hyporesponsiveness to aldosterone could be a significant factor in neonatal fluid and sodium loss.
    • Understanding this mechanism is crucial for managing fluid balance in newborns, particularly premature infants.

    More Related Videos

    Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings14:40

    Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings

    Published on: October 25, 2015

    The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

    The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

    Published on: August 2, 2017

    Related Concept Videos

    Hormonal Regulation01:33

    Hormonal Regulation

    The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Hormones of the Adrenal Glands01:31

    Hormones of the Adrenal Glands

    Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
    The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
    Hormones Regulating Blood Glucose01:16

    Hormones Regulating Blood Glucose

    Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
    In addition to accelerating glucose uptake and utilization, insulin has...
    Glucagon-like Receptor Agonists01:24

    Glucagon-like Receptor Agonists

    Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
    GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...